N. Straznicky

发表

Change in Sympathetic Nerve Firing Pattern Associated with Dietary Weight Loss in the Metabolic Syndrome

Markus P. Schlaich, Elisabeth Lambert, M. Esler, 2011, Front. Physio..

Gastric bypass in Type 2 diabetes with BMI < 30: weight and weight loss have a major influence on outcomes

P. Zimmet, J. Dixon, Wei-Jei Lee, 2013, Diabetic medicine : a journal of the British Diabetic Association.

Sympathetic activity and markers of cardiovascular risk in nondiabetic severely obese patients: the effect of the initial 10% weight loss.

J. Dixon, G. Lambert, C. Hensman, 2014, American journal of hypertension.

Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome

P. Meikle, P. Mundra, B. Kingwell, 2018, Arteriosclerosis, thrombosis, and vascular biology.

Surgical approaches to the treatment of obesity

J. Dixon, G. Lambert, E. Lambert, 2011, Nature Reviews Gastroenterology &Hepatology.

Cholesterol efflux from macrophages is influenced differentially by plasmas from overweight insulin-sensitive and -resistant subjects

D. Sviridov, P. Nestel, N. Straznicky, 2012, International Journal of Obesity.

Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss

J. Mariani, J. Dixon, P. Nestel, 2015, Cardiovascular Diabetology.

Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndrome.

J. Dixon, P. Nestel, D. Hering, 2015, The Journal of clinical endocrinology and metabolism.

Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.

H. Krum, M. Böhm, R. Schmieder, 2013, International journal of cardiology.

Differing Pattern of Sympathoexcitation in Normal-Weight and Obesity-Related Hypertension

M. Esler, T. Dawood, G. Lambert, 2007, Hypertension.

Comparison of endothelial function and sympathetic nervous system activity along the glucose continuum in individuals with differing metabolic risk profiles and low dietary sodium intake

G. Jerums, J. Dixon, G. Lambert, 2019, BMJ Open Diabetes Research & Care.

Markers of sympathetic nervous system activity associate with complex plasma lipids in metabolic syndrome subjects.

P. Meikle, P. Mundra, P. Nestel, 2017, Atherosclerosis.

Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity.

P. Meikle, P. Nestel, D. Tull, 2014, The American journal of clinical nutrition.

Neural mechanisms and management of obesity-related hypertension

M. Esler, E. Lambert, N. Eikelis, 2008, Current cardiology reports.

Effects of Moxonidine and Low‐Calorie Diet: Cardiometabolic Benefits from Combination of Both Therapies

J. Dixon, M. Esler, G. Lambert, 2017, Obesity.

Sympathetic activation and endothelial dysfunction in polycystic ovary syndrome are not explained by either obesity or insulin resistance

B. de Courten, J. Dixon, H. Teede, 2015, Clinical endocrinology.

European Society of Hypertens ion Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions

G. Grassi, J. Redón, J. Jordan, 2009 .

Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss

G. Lambert, E. Lambert, N. Straznicky, 2010, Current opinion in lipidology.

Gender differences in sympathetic nervous activity: influence of body mass and blood pressure

M. Esler, T. Dawood, G. Lambert, 2007, Journal of hypertension.

Sympathetic activation in chronic renal failure.

M. Esler, G. Lambert, E. Lambert, 2009, Journal of the American Society of Nephrology : JASN.

Plasma lipocalin-2/NGAL is stable over 12 weeks and is not modulated by exercise or dieting

M. Esler, F. Marques, M. Nakai, 2021, Scientific Reports.

Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects.

J. Dixon, P. Nestel, M. Esler, 2012, The Journal of clinical endocrinology and metabolism.

Weight Loss May Reverse Blunted Sympathetic Neural Responsiveness to Glucose Ingestion in Obese Subjects With Metabolic Syndrome

P. Nestel, M. Esler, T. Dawood, 2009, Diabetes.

European Society of Hypertension Working Group on Obesity Obesity-induced hypertension and target organ damage: current knowledge and future directions.

G. Grassi, J. Redón, J. Jordan, 2009, Journal of hypertension.

Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects

B. Courten, M. Cooper, B. Kingwell, 2013, Amino Acids.

Leptin-Receptor Polymorphisms Relate to Obesity through Blunted Leptin-Mediated Sympathetic Nerve Activation in a Caucasian Male Population

T. Ogihara, T. Katsuya, M. Esler, 2008, Hypertension Research.

Does sympathetic dysfunction occur before denervation in pure autonomic failure?

M. Esler, G. Lambert, E. Lambert, 2018, Clinical science.

Predicting the Glycemic Response to Gastric Bypass Surgery in Patients With Type 2 Diabetes

J. Dixon, L. Chuang, Wei-Jei Lee, 2012, Diabetes Care.

Serum uric acid and the relationship with subclinical organ damage in adults

J. Dixon, G. Lambert, E. Lambert, 2017, Journal of hypertension.

Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.

J. Dixon, P. Nestel, K. Richards, 2015, Metabolism: clinical and experimental.

Cardiac risk factor management Experience of an outpatient hypertension clinic

J. McNeil, H. Krum, L. Howes, 1991, The Medical journal of Australia.

Inverse association between sympathetic nervous system activity and bone mass in middle aged overweight individuals.

J. Dixon, G. Lambert, E. Lambert, 2018, Bone.

Endothelial Function in Healthy Young Individuals Is Associated with Dietary Consumption of Saturated Fat

J. Dixon, G. Lambert, E. Lambert, 2017, Front. Physiol..

Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial.

M. Cooper, B. Kingwell, C. Schalkwijk, 2016, The American journal of clinical nutrition.

In reply

L. Howes, N. Straznicky, W. Louis, 1991 .

Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.

J. Mariani, P. Nestel, M. Esler, 2009, The American journal of clinical nutrition.

Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications.

J. Dixon, G. Lambert, E. Lambert, 2010, Pharmacology & therapeutics.

A sympathetic view of human obesity

G. Lambert, E. Lambert, N. Straznicky, 2013, Clinical Autonomic Research.

Autonomic Nervous System: Metabolic Function

P. Nestel, M. Esler, N. Straznicky, 2009 .

Ghrelin Modulates Sympathetic Nervous System Activity and Stress Response in Lean and Overweight Men

J. Dixon, M. Esler, T. Dawood, 2011, Hypertension.

The effects of dietary lipid modification on blood pressure, cardiovascular reactivity and sympathetic activity in man

L. Howes, W. Louis, N. Straznicky, 1993, Journal of hypertension.

Fat‐free mass loss generated with weight loss in overweight and obese adults: what may we expect?

J. Dixon, G. Lambert, E. Lambert, 2015, Diabetes, obesity & metabolism.

Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects

B. Courten, M. Cooper, B. Kingwell, 2014, Amino Acids.

Mechanisms of sympathetic activation in obesity-related hypertension.

Elisabeth Lambert, Murray Esler, M. Esler, 2006, Hypertension.

European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality?

G. Grassi, J. Jordan, J. Dixon, 2010, Journal of hypertension.

Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity?

J. Dixon, G. Lambert, E. Lambert, 2015, American journal of physiology. Heart and circulatory physiology.

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.

P. Nestel, M. Esler, G. Lambert, 2005, The Journal of clinical endocrinology and metabolism.

The Effects of Exercise Training in Addition to Energy Restriction on Functional Capacities and Body Composition in Obese Adults during Weight Loss: A Systematic Review

J. Dixon, S. Fraser, S. Selig, 2013, PloS one.

Metabolic syndrome: a sympathetic disease?

G. Lambert, E. Lambert, M. Schlaich, 2015, The lancet. Diabetes & endocrinology.

A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women

W. Louis, N. Straznicky, P. Branley, 1998, Journal of Hypertension.

SINGLE‐UNIT SYMPATHETIC DISCHARGE PATTERN IN PATHOLOGICAL CONDITIONS ASSOCIATED WITH ELEVATED CARDIOVASCULAR RISK

M. Esler, T. Dawood, G. Lambert, 2008, Clinical and experimental pharmacology & physiology.

Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure

M. Esler, T. Dawood, G. Lambert, 2010, Journal of hypertension.

Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure

M. Cooper, B. Kingwell, B. de Courten, 2014, Clinical chemistry and laboratory medicine.

A polymorphism in the norepinephrine transporter gene is associated with affective and cardiovascular disease through a microRNA mechanism

M. Esler, F. Marques, D. Hering, 2017, Molecular Psychiatry.

Interrupting prolonged sitting in type 2 diabetes: nocturnal persistence of improved glycaemic control

N. Owen, D. Dunstan, E. Cerin, 2017, Diabetologia.

Interrupting prolonged sitting with brief bouts of light walking or simple resistance activities reduces resting blood pressure and plasma noradrenaline in type 2 diabetes

N. Owen, D. Dunstan, E. Cerin, 2016, Journal of hypertension.

Benefits for Type 2 Diabetes of Interrupting Prolonged Sitting With Brief Bouts of Light Walking or Simple Resistance Activities

David W. Dunstan, Bronwyn A. Kingwell, Ester Cerin, 2016, Diabetes Care.

The functional and clinical outcomes of exercise training following a very low energy diet for severely obese women: study protocol for a randomised controlled trial

J. Dixon, S. Fraser, S. Selig, 2016, Trials.

Laparoscopic Adjustable Gastric Banding and Other Devices for the Management of Obesity

J. Dixon, G. Lambert, E. Lambert, 2012, Circulation.

A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.

J. Dixon, P. Nestel, K. Richards, 2014, The Journal of clinical endocrinology and metabolism.

Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females.

J. Dixon, M. Esler, D. Hering, 2013, American journal of hypertension.

Sympathetic Nervous System Activity Is Associated With Obesity-Induced Subclinical Organ Damage in Young Adults

M. Esler, T. Dawood, G. Lambert, 2010, Hypertension.

Renal denervation: a potential new treatment modality for polycystic ovary syndrome?

Michael Böhm, Reena Chopra, Felix Mahfoud, 2011, Journal of hypertension.

Neuroadrenergic Dysfunction Along the Diabetes Continuum

J. Dixon, P. Nestel, M. Esler, 2012, Diabetes.

393 NEUROADRENERGIC DYSFUNCTION ALONG THE DIABETIC CONTINUUM: A COMPARATIVE STUDY IN OBESE METABOLIC SYNDROME SUBJECTS

J. Dixon, P. Nestel, M. Esler, 2012 .

Sympathetic Neural Adaptation to Hypocaloric Diet With or Without Exercise Training in Obese Metabolic Syndrome Subjects

J. Mariani, B. de Courten, P. Nestel, 2009, Diabetes.

The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.

P. Nestel, M. Esler, T. Dawood, 2011, The Journal of clinical endocrinology and metabolism.

Norepinephrine transporter expression is inversely associated with glycaemic indices: a pilot study in metabolically diverse persons with overweight and obesity

J. Mariani, J. Dixon, M. Esler, 2016, Obesity science & practice.

Mediators of sympathetic activation in metabolic syndrome obesity

M. Esler, E. Lambert, N. Eikelis, 2008, Current hypertension reports.

Augmented endothelial‐specific L‐arginine transport prevents obesity‐induced hypertension

D. Kaye, R. Evans, N. Rajapakse, 2014, Acta physiologica.

Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss

J. Mariani, J. Dixon, D. Hering, 2016, Front. Physiol..

The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.

J. Dixon, P. Nestel, K. Richards, 2013, The Journal of clinical endocrinology and metabolism.

Muscle Sympathetic Nerve Activity Is Associated With Elements of the Plasma Lipidomic Profile in Young Asian Adults

P. Meikle, P. Mundra, J. Dixon, 2017, The Journal of clinical endocrinology and metabolism.

Interrupting prolonged sitting reduces resting blood pressure in adults with type 2 diabetes

N. Owen, D. Dunstan, J. Sacre, 2015 .

Effect of Diet versus Diet and Exercise on Weight Loss and Body Composition in Class II and III Obesity: A Systematic Review

J. Dixon, S. Fraser, S. Selig, 2013 .

Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals

J. Mariani, P. Nestel, T. Dawood, 2011, Journal of hypertension.

The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjects

J. Dixon, P. Nestel, T. Dawood, 2012, Diabetes, obesity & metabolism.

Sympathetic Nervous System Activity Is Associated With Obesity-Induced Subclinical Organ Damage in Young Adults

M. Esler, T. Dawood, G. Lambert, 2010, Hypertension.

The effects of dietary weight loss on indices of norepinephrine turnover: Modulatory influence of hyperinsulinemia

J. Dixon, P. Nestel, M. Esler, 2014, Obesity.

Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity.

P. Meikle, P. Nestel, D. Tull, 2014, The American journal of clinical nutrition.

Benefits for Type 2 Diabetes of Interrupting Prolonged Sitting With Brief Bouts of Light Walking or Simple Resistance Activities

N. Owen, D. Dunstan, E. Cerin, 2016, Diabetes Care.

Neck Circumference Is Associated with Muscle Sympathetic Nerve Activity in Overweight and Obese Men but Not Women

J. Dixon, P. Nestel, G. Lambert, 2017, Front. Physiol..

Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.

J. Mariani, P. Nestel, M. Esler, 2009, The American journal of clinical nutrition.

Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss

G. Lambert, E. Lambert, N. Straznicky, 2010, Current opinion in lipidology.

Fat‐free mass loss generated with weight loss in overweight and obese adults: what may we expect?

N. Straznicky, M. Grima, Elisabeth Lambert, 2015, Diabetes, obesity & metabolism.

Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension.

L. Howes, W. Louis, N. Straznicky, 1995, The American journal of cardiology.